TBX2 and neoplasm: We confirmed endogenous TBX2 overexpression in three ER-positive luminal tumor lines (MCF7, MDA-MB361, and BT-474) (Figure S3A–C) that have previously been shown to harbor TBX2 gene amplifications [6], [9], [10].